MetLife Inc is projected to report Q3 2026 consensus revenue of $19.12 billion and EPS of $2.71, with its stock currently priced at $88.42 relative to a $95.15 average analyst target.
Investors are closely monitoring the Q3 2026 analyst consensus for Variable Investment Income (VII), as market fluctuations influence the performance of private equity and alternative investment portfolios.
Robust performance in the Group Benefits segment remains a key pillar for earnings stability amid shifting interest rate expectations. Analysts will also seek clarity on the company’s capital allocation strategy, specifically regarding the pace of share buybacks for the remainder of the fiscal year.